PHARM-- heart failure Flashcards

1
Q

3 things for primary prevention of HF (stage A)

A
  • control BP
  • SGLT2i in T2DM and CVD or high risk for CVD
  • optimal CVD managment in pt w/ CVD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2 things for preventing the HF syndrome (stage B)

A
  • ACE in pt w/ LVEF < 40% (arb if intolerant)
  • BB in pt w/ LVEF < 40%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

4 core stage C HFrEF meds and 1 PRN

A
  • ARNI (or ACEi, ARB)
  • BB
  • AA
  • SGLT2inhibitors
  • Loop diuretics PRN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

black pt w/ persistent HFrEF should get what med

A

hydralazine/ISDN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pt w/ persistent HFrEF w/ EF < 35% should get what

A

ICD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  • Single most effective for mortality benefit in HFrEF
  • Proven to delay HF progression at all stages
  • in HFpEF its used to manage HTN, DM, CKD
A

ACEi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

if pt on ACE has cough what do you do first?

A
  • assess fluid status first before stopping
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which two classes should you abrupt discontinuation

A

ACE
ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • Sacubitril inhibits neprilysin to increase levels of natriuretic peptides which counters ATII
  • Reduces mortality & hospitalization for chronic HF (class II-III) w/ reduced EF
  • higher risk of angioedema than ARB alone; not to be used in h/o angioedema
A

ARNI (sacubitril/valsartan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

these are C/I of what

  • Pregnancy
  • h/o angioedema
  • Severe hepatic imp. (child-pugh C)
  • Concurrent Use of ACEi, aliskiren in DM or other ARB
A

ARNI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Must use NT-proBNP to monitor BNP levels in HF diagnosis when prescribing which med?

A

ARNI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • blocks NE to decrease afterload & HR while improving SV
  • decreases remodeling
  • increases EF longterm (after initial decline)
  • prevents arrhythmias
A
  • metroprolol
  • carvedilol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

when is BB used in HF

A
  • used in HFrEF w/ no or minimal evidence of fluid retention
  • added in stage B usually after ACE/ARB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

which class has these C/I

High degree heart block
Sick sinus syndrome
Severe asthma/COPD (caution)
Vasospastic angina

A

BB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which class has these ADRs

  • Hypotension, brady
  • 1st deg. Heart block
  • Bronchospasms
  • Glucose intolerance (non-vasodilating BB)
  • Impotence
  • Feeling cold
A

BB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when do we use BB in HFpEF

A

only if they have an arrhythmia like afib or aflutter too

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

if patient is ____ and ____ do not start BB therapy

A

not euvolemic and hospitalized d/t HF excerbation

18
Q

to manage many ADR of BB, you should adjust does of what two meds beforehand?

A

ACE & diuretics

19
Q

3 requirements inorder to use spironolactone in Stage C HFrEF

A
  • EF < 35
  • CrCl >30 or SCr 2.5+
  • K+ < 5
20
Q

3 requirements inorder to use spironolactone in Stage C HFpEF

A
  • EF over 45 + elevated BNP or HF hospitalization w/in 1 yr
  • CrCl over 30 or SCr under 2.5
  • K+ < 5
21
Q

which med has these C/I

renal failure
hyponatremia

A

spironolactone

22
Q

these are ADR of what med

  • Hyperkalemia
  • Gynecomastia, breast tenderness
  • Hirsutism
  • Menstrual changes
  • Metabolic acidosis
A

spironolactone

23
Q

a weak diuretic and aldosterone antagonist that decreases mortality

A

spironolactone

24
Q

Inhibits water transport across loop of Henle → increased water, Cl-, Na+, K+ excretion

A

furosemide

25
recommended in anyone w/ evidence of fluid retention to improve sx and prevent worsening HF
diuretics
26
why must furosemide be used in combo w/ vasodilator (ARNI/ACE/ARB)?
to minimize RAAS stimulation since increasing diuresis will decrease preload
27
why are loop diuretics preferred in HF (2)
* superior fluid clearance that works despite renal impairment * increasing dose increases diuretic response
28
# these ADRs belong to what medication * hypotension * electrolyte imablanc * alkalosis * dehydration * gout * ototoxicity w/ IV form
furosemide
29
2 indications for for hydralazine/ISDN
* intolerant to ACE/ARB/ARNI * add-on in black pts w/ stage C HFrEF who remain symptomatic
30
reduces resistance to LV ejection decreases ventricular filling pressure increases SV
hydralazine/ISDN
31
role of hydralazine & ISDN in the combo form
* hydralazine: direct vasodilator (decreases afterload) * ISDN: increases NO concentration (decreases preload & afterload)
32
vasodilator added after optimizing GDMT in patients w/ symptomatic HF to **decrease hospitalization**
digoxin
33
* (+) inotrope * (-) chronotrope * inhibit renin production
digoxin (digitalis)
34
which med should you Monitor doses w/ pulmonary artery catheter
milrinone
35
# these are ADRs of what * Hypotension * Ventricular arrhythmia * Reflex tachycardia * thrombocytopenia
the IV positive inotropes (dobutamine & milrinone)
36
with which med is concurrent BB use a C/I?
dobutamine
37
* CNS-- fatigue, weakness, confusion, insomnia * GI- anorexia, N/V/D * Visual-- halos, hazy, blurry * Cardiac-- SA/AV node dep., AV block, arrhythmias * Predispose. Low K,Mg and high Ca
digoxin ADR
38
toxicity that causes hyperkalemia; managed with DSFab, Mg
digitalis toxicity
39
combining which 3 meds increases risk of hyperkalemia
ACE + ARB + AA
40
which 3 meds have no mortality benefit
* digoxin * furosemide * IV positive inotropes